Anti-Aging / Longevity
Cartalax
Cartalax is a synthetic tripeptide (Ala-Glu-Asp) developed as part of the Khavinson peptide bioregulator series. It targets cartilage tissue and has been investigated for its potential geroprotective effects on connective tissue maintenance and longevity. Research suggests it may modulate gene expression related to cartilage matrix synthesis and cellular senescence.
Quick Facts
Also known asAED peptide, T-31, AC-4 peptide complex
CategoryAnti-Aging / Longevity
Routesoral, subcutaneous, topical
Chain length3 amino acids
SequenceAla-Glu-Asp
FDA statusNot approved
StorageRoom temperature (15-25°C). Reconstituted: 90 days.
Dosing Protocols
| Goal | Dose | Frequency | Route | Cycle | Notes |
|---|---|---|---|---|---|
| Standard Oral Protocol | 100 mcg | 1x/day | oral | 9 weeks | 100mcg (0.1mg) capsule daily with meals. 1-3 month cycle. |
| Intensive Oral Protocol | 200 mcg | 1x/day | oral | 9 weeks | 200mcg (2 capsules) daily with meals. 1-3 month cycle. |
| Maintenance Oral Protocol | 100 mcg | every other day | oral | 9 weeks | 100mcg every other day with food. 1-3 month cycle. |
| Standard Injectable Protocol | 700 mcg | 1x/day | subcutaneous | 4 weeks | 10mcg/kg body weight daily (700mcg for 70kg individual). 20-30 day cycle. |
| Intensive Injectable Protocol | 1.1 mg | 1x/day | subcutaneous | 4 weeks | 15mcg/kg body weight daily (1050mcg for 70kg). 20-30 day cycle. |
Protocols shown are for informational purposes only. Consult a healthcare provider before starting any peptide protocol.
Track Your Cartalax Protocol
Log doses, manage vial inventory, set injection reminders, and visualize blood concentration levels.
Start Tracking — FreeCommon Questions
What is the typical dose of Cartalax?
A common dose for Cartalax is 100 mcg 1x/day via oral. 100mcg (0.1mg) capsule daily with meals. 1-3 month cycle.
How should I store Cartalax?
Store Cartalax at Room temperature (15-25°C). Short bioregulatory peptide typically available in capsule form. Store in a cool, dry place. No reconstitution needed for oral formulations. Once reconstituted, use within 90 days.
Is Cartalax FDA approved?
Cartalax is not FDA approved and is available for research purposes only. It has not been evaluated by the FDA for safety or efficacy in humans.